More on IOVA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (6.7 Score)

Upcoming Events

- Earnings (11/5/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Iovance Biotherapeutics (NQ:IOVA)
Delayed: 14.09 -0.05 (0.35%)
Prev. Close $14.14  
Open$14.19 
52 Wk High$ 
52 Wk Low$ 
Day High$14.30 
Day Low$13.54 
P/E N/A  
EPS$ 
Volume7,758,971 

Friends, Peers and Foes (?): FATE, GTBP, IBRX, NKTX, NTHI (more...)

Oct 23, 2026 10:15 AM Iovance Presents New Data at ESMO 2026 Demonstrating Deep, Durable Responses with Lifileucel TIL Cell Therapy Plus Pembrolizumab in Frontline Advanced Melanoma
Oct 19, 2026 07:00 AM Iovance Highlights TIL Cell Therapy Platform Across Solid Tumors at the European Society for Medical Oncology (ESMO) Congress 2026
Oct 16, 2026 05:15 PM Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Oct 13, 2026 03:35 AM Iovanace Biotherapeutics (IOVA) PT Raised to $18 at Barclays
Oct 8, 2026 07:24 AM Iovanace Biotherapeutics (IOVA) PT Raised to $11 at Baird
Oct 5, 2026 05:01 PM Form 8-K IOVANCE BIOTHERAPEUTICS, For: Oct 05
Oct 2, 2026 05:01 PM Form 4 IOVANCE BIOTHERAPEUTICS, For: Sep 30 Filed by: Berkowitz Noah
Oct 2, 2026 05:00 PM Form 3 IOVANCE BIOTHERAPEUTICS, For: Sep 30 Filed by: Berkowitz Noah
Oct 1, 2026 07:00 AM Iovance names Noah Berkowitz as chief medical officer
Oct 1, 2026 07:00 AM Iovance Biotherapeutics Appoints Noah Berkowitz, M.D., Ph.D., as Chief Medical Officer
View All Articles

Entities mentioned with IOVA

View All Entities